Physiological Concentrations of Insulin Induce Endothelin-Dependent Vasoconstriction of Skeletal Muscle Resistance Arteries in the Presence of Tumor Necrosis Factor-α Dependence on c-Jun N-Terminal Kinase
Authors:
- Etto C. EringaEEEtto C. Eringa
- Nico WesterhofNWNico Westerhof
- Pieter SipkemaPSPieter Sipkema
- Bradley EBEBradley E
- Stehouwer CSCStehouwer C
- Korstjens IKIKorstjens I
- van Nieuw Amerongen GVGvan Nieuw Amerongen G
- Musters RMRMusters R
Open Access
- 1 February 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (2) , 274-280
Abstract
Objective— Tumor necrosis factor-α (TNF-α) has been linked to obesity-related insulin resistance and impaired endothelium-dependent vasodilatation, but the mechanisms have not been elucidated. To investigate whether TNF-α directly impairs insulin-mediated vasoreactivity in skeletal muscle resistance arteries and the role of c-Jun N-terminal kinase (JNK) in this interference. Methods and Results— Insulin-mediated vasoreactivity of isolated resistance arteries of the rat cremaster muscle to insulin (4 to 3400 μU/mL) was studied in the absence and presence of TNF-α (10 ng/mL). Although insulin or TNF-α alone did not affect arterial diameter, insulin induced dose-dependent vasoconstriction of cremaster resistance arteries in the presence of TNF-α, (−12±1% at 272 μU/mL). Blocking endothelin receptors in the absence of TNF-α uncovered insulin-mediated vasodilatation (18±6% at 272 μU/mL) but not in the presence of TNF-α (2±2% at 272 μU/mL), showing that TNF-α inhibits vasodilator effects of insulin. Using digital imaging microscopy, we discovered that TNF-α activates JNK in arterial endothelium, visible as an increase in phosphorylated JNK. Moreover, inhibition of JNK with the cell-permeable peptide inhibitor L-JNKI abolished insulin-mediated vasoconstriction in the presence of TNF-α, showing that JNK is required for interaction between TNF-α and insulin. Conclusions— TNF-α inhibits vasodilator but not vasoconstrictor effects of insulin in skeletal muscle resistance arteries, resulting in insulin-mediated vasoconstriction in the presence of TNF-α. This effect of TNF-α is critically dependent on TNF-α–mediated activation of JNK.Keywords
This publication has 28 references indexed in Scilit:
- Tumor Necrosis Factor-α Inhibits Insulin’s Stimulating Effect on Glucose Uptake and Endothelium-Dependent Vasodilation in HumansCirculation, 2003
- Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factor-treated Cells through Targeting Multiple Serine KinasesJournal of Biological Chemistry, 2003
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Salicylic Acid Reverses Phorbol 12-Myristate-13-Acetate (PMA)- and Tumor Necrosis Factor α (TNFα)-induced Insulin Receptor Substrate 1 (IRS1) Serine 307 Phosphorylation and Insulin Resistance in Human Embryonic Kidney 293 (HEK293) CellsJournal of Biological Chemistry, 2003
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Ageing Is Associated with a Prolonged Fever Response in Human EndotoxemiaClinical and Diagnostic Laboratory Immunology, 2001
- Obesity and insulin resistanceJournal of Clinical Investigation, 2000
- Acute modulation of endothelial Akt/PKB activity alters nitric oxide–dependent vasomotor activity in vivoJournal of Clinical Investigation, 2000
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Circulating Endothelin-1 Levels Increase During Euglycemic, Hyperinsulinemic Clamp in Lean NIDDM MenDiabetes Care, 1995